Teenagers and those with severe reactions are more likely to use their epinephrine autoinjector in cases of anaphylaxis in Canada

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1073-1075.e3. doi: 10.1016/j.jaip.2018.07.044. Epub 2018 Aug 28.
No abstract available

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anaphylaxis / drug therapy*
  • Bronchodilator Agents / therapeutic use*
  • Canada
  • Drug Utilization / statistics & numerical data
  • Epinephrine / therapeutic use*
  • Female
  • Humans
  • Injections, Intramuscular
  • Male
  • Severity of Illness Index
  • Young Adult

Substances

  • Bronchodilator Agents
  • Epinephrine